FLASH - Biocorp - Strong Buy - TP: €38
Biocorp is on track with its operational schedule, recognizing the first Mallya sales in 2022. The order book for H1-2023 is in line with our expectations, although we remain cautious for H2.Biocorp Production SA is a France-based company, which is specialised in the development and manufacturing of medical and drug delivery devices.
Portzamparc is a subsidary of BNP Paribas which adapted the mission to contribute to responsible and sustainable growth of private clients, management companies and SMEs . They offer personalized support adapted to the objectives in particular for Small and Medium-Sized Enterprises.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.